An increasing number of studies have revealed direct connections between abnormal Hsp90 expression and cellular factors related to PAH, such as soluble guanylate cyclase and AMP-activated protein kinase. The gene discussed is HSP90AA1; the disease is pulmonary arterial hypertension.